Overview

Functional Neuroimaging in Depression

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Oral administration of escitalopram during 8 weeks; PET scan with 18F-FDG at inclusion and after 8 weeks
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Ghent
Collaborators:
Fund for Scientific Research, Flanders, Belgium
H. Lundbeck A/S
Treatments:
Citalopram
Dexetimide